A Summary of the Clinical Practice Guidelines for the Management of Patients with Peripheral Arterial Disease in Myanmar

  • Than Than Aye Department of Medicine, North Okkalapa General Hospital, University of Medicine (2), Yangon, Myanmar
  • Tint Swe Latt University of Medicine (2), Yangon, Myanmar
  • Khin Mg Lwin Department of Cardiac Surgery, University of Medicine (1), Yangon, Myanmar
  • Win Win Kyaw Department of Cardiac Surgery, University of Medicine (2), Yangon, Myanmar
  • Myint Soe Win Department of Cardiology, University of Medicine (2), Yangon, Myanmar
  • Moe Wint Aung Department of Medicine, Yangon General Hospital, University of Medicine (1), Yangon, Myanmar
  • Ko Ko Department of Medicine, North Okkalapa General Hospital, University of Medicine (2), Yangon, Myanmar
  • Thein Myint Department of Medicine, North Okkalapa General Hospital, University of Medicine (2), Yangon, Myanmar
  • Yin Yin Win Department of Medicine, North Okkalapa General Hospital, University of Medicine (2), Yangon, Myanmar


Peripheral artery disease (PAD) broadly encompasses vascular diseases caused primarily by atherosclerosis and thromboembolic pathophysiologic processes that alter the normal structure and function of the aorta, its visceral arterial branches, and the arteries of the lower extremity.  The aims of the Myanmar clinical practice guidelines for the management of patients with PAD are to assist physicians in selecting the best management strategies for an individual patient with peripheral artery disease with main focus on lower extremity artery disease (LEAD) due to atherosclerosis, to help the physician to make decisions in their daily practice, and to aid in appropriate referrals to specialists. Early detection and treatment guidelines for the treatment of PAD are important to reduce the morbidity and mortality of patients with vascular problems in Myanmar.


Download data is not yet available.


Steg PG, Bhatt DL, Wilson PW, D’Agostino R Sr, Ohman EM, Rother J, et al. One-year cardiovascular event rates in out patients with atherothrombosis. JAMA 2007;297:1197–1206.

Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381–386.

The 2011 ACCF/AHA Focused update of the guideline for the management of patients with peripheral artery disease J Am Coll Cardiol 2011;58:2020-2045 and the 2005 ACC/AHA guidelines for the management of patients with peripheral artery disease (lower extremity, renal, mesenteric, and abdominal aortic) J Am Coll Cardiol 2006;47:1239-312.

Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-Society consensus for the management of peripheral arterial disease (TASC II).JVascSurg 2007;45:S5–S67.

ESC Guidelines on the Diagnosis and Treatment of Peripheral artery diseases. European Heart J 2011;32:2851-2906.

Tsai, AW, Folsom, AR, Rosamond, WD, Jones, DW . Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study. Stroke 2001; 32: 1721–24.

Fowkes, FG, Housley, E, Cawood, EH, Macintyre, CC,Ruckley, CV, Prescott, RJ . Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384–92.

Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly. The Rotterdam Study Arterioscler Thromb Vasc Biol. 1998; 185–192.

Allison, MA, Criqui, MH, McClelland, RL. The effect of novel cardiovascular risk factors on the ethnic specific odds for peripheral arterial disease in the Multi- Ethnic Study of Atherosclerosis (MESA) J Am Coll Cardiol 2006;48: 1190–97.

Selvin, E, Erlinger, TP . Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey,1999–2000. Circulation 2004;110: 738–43.

Kroger K, Stang A, Kondratieva J, Moebus S, Beck E, Schmermund A,et al. Prevalence of peripheral arterial disease—results of the Heinz Nixdorf recall study. Eur J Epidemiol 2006;21:279–285.

Criqui MH. Peripheral arterial disease epidemiological aspects.Vasc Med 2001;6:3–7.

Hirsch, AT, Criqui, MH, Treat-Jacobson, D. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286: 1317–24.

Fowkes FG, Housley E, Riemersma RA, Macintyre CC, Cawood EH, Prescott RJ, Ruckley CV. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331–340.

Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 1996;25:282–290.

Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A,Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam Study. ArteriosclerThrombVascBiol 1998;18:185–192.

Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a),and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001;285:2481 2485.

Dormandy JA, Rutherford RB, for the TASC Working Group. TransAtlanticInter Society Consensus (TASC). Management of peripheral arterial disease (PAD). J Vas Surg 2000;31:S1-S296.

Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J ClinEpidemiol 1992;45:1101–1109.

Stoffers HE, Kester AD, Kaiser V, Rinkens PE, Kitslaar PJ, Knottnerus JA. The diagnostic value of the measurement of the ankle–brachial systolic pressure index in primary health care. J ClinEpidemiol 1996;49:1401–1405.

Schroder F, Diehm N, Kareem S, Ames M, Pira A, Zwettler U, LawallH,Diehm C. A modified calculation of ankle–brachial pressure index is far more sensitive in the detection of peripheral arterial disease. J VascSurg 2006;44:531–536.

Stein R, Hriljac I, Halperin JL, Gustavson SM, Teodorescu V, Olin JW. Limitation of the resting ankle–brachial index in symptomatic patients with peripheral arterial disease.Vasc Med 2006;11:29–33.

Lijmer JG, Hunink MG, van den Dungen JJ, Loonstra J, Smit AJ. ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol 1996;22:391–398.

Koelemay MJ, den Hartog D, Prins MH, Kromhout JG, Legemate DA, Jacobs MJ. Diagnosis of arterial disease of the lower extremities with duplex ultrasonography.Br J Surg 1996;83:404–409.

Visser K, Hunink MG. Peripheral arterial disease: gadolinium-enhanced MRangiography versus color-guided duplex US—a meta-analysis. Radiology 2000;216:67–77.

Collins R, Cranny G, Burch J, Aguiar-Ibanez R, Craig D, Wright K,et al. A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess 2007;11:iii–iv, xi–xiii, 1–184.

Bandyk DF, Chauvapun JP. Duplex ultrasound surveillance can be worth while after arterial intervention. Perspect Vasc Surg Endovasc Ther 2007;19:354–359;discussion 360–351.

Ferris BL, Mills JL Sr, Hughes JD, Durrani T, Knox R. Is early postoperative duplex scan surveillance of leg bypass grafts clinically important? J VascSurg 2003;37:495–500.

Barnes RW. Noninvasive diagnostic assessment of peripheral vascular disease. Circulation 1991;83:I20–I27.

Clement DL, Van Maele GO, De Pue NY. Critical evaluation of venous occlusion plethysmography in the diagnosis of occlusive arterial diseases in the lowerlimbs. Int Angiol 1985;4:69–74.

Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: A systematic review and meta-analysis. JAMA 2009;301:415–424.

Poon E, Yucel EK, Pagan-Marin H, Kayne H. Iliac artery stenosis measurements:Comparison of two-dimensional time-of-flight and three-dimensional dynamic gadolinium-enhanced MR angiography. AJR Am J Roentgenol 1997;169:1139–1144.

Ho KY, de Haan MW, Kessels AG, Kitslaar PJ, van Engelshoven JM. Peripheralvascular tree stenoses: detection with subtracted and nonsubtracted MR angiography.Radiology1998;206:673–681.

Quinn SF, Sheley RC, Semonsen KG, Leonardo VJ, Kojima K, SzumowskiJ.Aortic and lower-extremity arterial disease: evaluation with MR angiography versus conventional angiography. Radiology 1998;206:693–701.

Nelemans PJ, Leiner T, de Vet HC, van Engelshoven JM. Peripheral arterial disease: Meta-analysis of the diagnostic performance of MR angiography. Radiology 2000;217:105–114.

Koelemay MJ, Lijmer JG, Stoker J, Legemate DA, Bossuyt PM. Magnetic resonance angiography for the evaluation of lower extremity arterial disease: A meta-analysis. JAMA 2001;285:1338–1345.

Ouwendijk R, de Vries M, Stijnen T, Pattynama PM, van Sambeek MR, ButhJ,et al. Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial. AJR Am J Roentgenol 2008;190:1349–1357.

Hingorani A, Ascher E, Marks N. Preprocedural imaging: New options to reduceneed for contrast angiography. SeminVascSurg 2007;20:15–28.

Astrup A, Dyerberg J, Elwood P, Hermansen K, Hu FB, Jakobsen MU, et al. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: Where does the evidence stand in 2010? Am J Clin Nutr 2011;93:684–688.

He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. Accumulated evidence on fish consumption and coronary heart disease mortality: A meta-analysis of cohort studies. Circulation 2004;109:2705–2711.

Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med 2006;354:1601–1613.

Dauchet L, Amouyel P, Hercberg S, Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr 2006;136:2588–2593.

He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: Meta-analysis of cohort studies. Lancet 2006;367:320–326

How to Cite
Than Aye, T., Latt, T. S., Lwin, K. M., Kyaw, W. W., Win, M. S., Aung, M. W., Ko, K., Myint, T., & Win, Y. Y. (2014). A Summary of the Clinical Practice Guidelines for the Management of Patients with Peripheral Arterial Disease in Myanmar. Journal of the ASEAN Federation of Endocrine Societies, 28(2), 114. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/64
Feature Articles